| Name | Kadoorie Study of Chronic Disease in China |
|---|---|
| Acronym | KSCDC |
| Last update | 02/05/2010 |
Principal investigators
|
Liming Lee (Prof.)
|
China Centre for Disease Control, China |
|
Zhengming Chen (Prof.)
|
Clinical Trial Service Unit & Epidemiological Studies Unit, Oxford University, United Kingdom |
Contacts
|
Liming Lee (Prof.)
|
Perking Union Medical College, Chinese Academy of Medical Sciences
Beijing 100730 Email: lmlee@vip.163.com |
|
Zhengming Chen (Prof.)
|
Clinical Trial Service Unit & Epidemiological Studies Unit
Oxford OX3 7LF Phone: +44-1865-743743 Email: Zhengming.chen@ctsu.ox.ac.uk |
Website
Funding agencies
During recent decades China has undergone a rapid transition in the main disease patterns of its population. There has been a substantial decrease in maternal and child mortality and in adult mortality from the main infectious/parasitic diseases, whereas for ischaemic heart disease and some other non-communicable chronic diseases, there has been a moderate increase in mortality rates, at least in some parts of China. Consequently, most of the premature mortality that still remains in China now involves the chronic diseases of middle age, such as cancer, stroke, heart disease, or chronic lung disease. For each major disease there are large unexplained variations in the age-specific rates between different parts of China, indicating that there must be some large avoidable causes. Large blood-based prospective studies are important ways of investigating many slow-acting causes of the common chronic diseases in the population.
The principal aim of the study is to assess reliably the effects of both established risk factors (such as smoking, alcohol, obesity, etc) and emerging risk factors (eg, genetic markers) for many different diseases, not only overall but also in a range of different circumstances (e.g., at different ages and at different levels of other risk factors).
|
Legend
|
| Study design | Cohort |
|---|---|
| Type of participants | Individuals |
| Target or final number of participants | 500000 |
| Target or final number of DNA | 500000 |
Selection criteria
|
|
Minimun: 30 years Maximun: 79 years |
|
|
China (Residents of 10 Chinese regions.) |
|
|
Participants were selected according to disease, exposure and demographic profiles as well as availability of research facilities. |
Recruitment procedures
In the 10 study areas, all men and women aged 35–74 who are permanently resident (for complete follow-up of mortality and morbidity) and without major disability in each administrative unit (village or street committee) will be identified and invited to participate.
Data Sources
| Cross-sectional | Repeated/continuous | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
Collection procedures
Following informed written consent, each study participant will undergo an interview and physical examination and will provide a blood sample for long-term storage. Information collected through face-to-face interview will cover a broad range of variables, and many physical aspects are also to be measured.
Follow up procedures
At 5 year intervals, a reasonably representative sample of ~15 000 (3%) surviving study participants will be invited for re-survey with repeat interviews, including the same measurements and blood collection procedures as those in the baseline survey. All study participants will be followed-up indefinitely for cause-specific mortality and for any hospitalised event through the death registries and health insurance claim systems that are now fully established at the 10 study sites.
Baseline principal variables of interest
Health information
Physical / Biochemical measures
|
|
|
|
|
Sociodemographic Characteristics
|
|
|
|
|
|
|
|
|
Socioeconomic Characteristics
|
|
|
|
|
Life habits / Behaviours
|
|
|
|
|
|
Physical environment
|
|
|
Sample management
Biological samples
|
|
|
|
|
|
|
|
|
Biological samples format
| Fresh | Frozen | Dried (paper) | Other | Specification | |
|---|---|---|---|---|---|
| Blood |
|
|
|
|
|
Legend
|
Allow access to data or samples to external researchers
|
|
|
|
Current status
| Phase | Start | End |
|---|---|---|
| Preparation phase/Pilot | -- | -- |
| Recruitment / initial data collection | 2004 | 2008 |
| Follow-up of participants | 2004 | 2025 |
| Current number of participants recruited | 513211 in date of 01/01/2010 |
|---|
| Current number of collected DNA samples | 513116 in date of 01/01/2010 |
|---|
| Document type | Availability | |
|---|---|---|
| 1 | General study protocol |
Zhengming.chen@ctsu.ox.ac.uk |
| 2 | Specific protocols/procedures (data collection, samples management, etc.) |
Zhengming.chen@ctsu.ox.ac.uk |
| 3 | Questionnaires |
Zhengming.chen@ctsu.ox.ac.uk |
| 4 | Physical and cognitive measures |
Zhengming.chen@ctsu.ox.ac.uk |
| 5 | DNA processing | |
| 6 | IT | |
| 7 | Ethics | |
| 8 | Consent forms |
Zhengming.chen@ctsu.ox.ac.uk |
| 9 | Pamphlet / project description |
Zhengming.chen@ctsu.ox.ac.uk |
| 10 | Governance / ethics documentation |
Zhengming.chen@ctsu.ox.ac.uk |
| 11 | Other |
| Name | Kadoorie Study of Chronic Disease in China Questionnaire |
|---|---|
| Last update | 03/18/2009 |
| Version or reference year | 2004 |
Questionnaire owner
Contact
|
Zhengming Chen (Prof.)
|
Clinical Trial Service Unit & Epidemiological Studies Unit
Oxford OX3 7LF Phone: +44-1865-743743 Email: Zhengming.chen@ctsu.ox.ac.uk |
Utilization conditions
Permission should be sought in advance.
Information on validity
A re-survey will be undertaken in 3-5% of the study participants, which will provide useful information about the validity of the questionnaire data collected.
References
|
Legend
|
Respondent
Administration environment
Administration mode
Administration format
Administration language
Available Format
NOTICE: HTML document format may differ slightly from the actual questionnaire. Please refer to the original PDF document for exact reproduction.
| Name | Kadoorie Study of Chronic Disease in China Questionnaire |
|---|---|
| Number of Question Blocks | 37 |
| Name | Physical and cognitive measures |
|---|---|
| Last update | 06/19/2009 |
| Collected at phase | Baseline |
Contacts
|
Zhengming Chen (Prof.)
|
Oxford OX3 7LF
Phone: +44-1865-743743 Email: Zhengming.chen@ctsu.ox.ac.uk |
|
Legend
|
Others body composition measures
(Fat percentage)
Cognitive functions (CIDI form)
FUNCTIONS OF THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS
Functions of the cardiovascular system
Functions of the respiratory system
Respiratory functions (Spirometry)
Others measures of the respiratory system
(CO level)
|
Legend
|
Administration environment
Hospital, clinic, university or recruitment center
Staff administering test
Professionals (nurses, clinicians, etc)
Interviewers/research assistants
Other
| Administration language | Chinese |
|---|
Standard operating procedures (SOPs) or reference information
| Name | Information Technologies |
|---|---|
| Study name | Kadoorie Study of Chronic Disease in China [KSCDC] |
| Last update | 10/28/2008 |
Contacts
|
Garry Lancaster (Dr)
|
CTSU, Richard Doll Building, Old Road Campus, University of Oxford
Oxford Phone: +44-1865-743 743 Email: garry.lancaster@ctsu.ox.ac.uk |
|
Xiaoming Yang (Dr)
|
CTSU, Richard Doll Building, Old Road Campus, University of Oxford
Oxford Phone: +44-1865-743 743 Email: xiaoming.yang@ctsu.ox.ac.uk |
|
Legend
|
Biobanking areas covered
Name and version of programming language
C++ Builder 5
Internal/external development
Shareability
Overall we have developed over 30 applications to support the whole project, using various programming languages and IT tools. All of them were developed in house and we are happy to share our experience and softwares with other research groups.